Genetic Technologies
GENE
$2.28
Share price
0.88%
Change (1 day)
132.65%
Change (1 year)
Categories
Genetic Technologies (GENE) - Cash on Hand
Cash on Hand as of December 2023 : $2.54 M
According to Genetic Technologies's latest financial reports the company has $2.54 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Genetic Technologies - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $5.19 M | -35.61% |
| 2022-06-30 | $8.07 M | -48.6% |
| 2021-06-30 | $15.7 M | 60.78% |
| 2020-06-30 | $9.76 M | 552.41% |
| 2019-06-30 | $1.49 M | -63.14% |
| 2018-06-30 | $4.06 M | -51.91% |
| 2017-06-30 | $8.44 M | 1.11% |
| 2016-06-30 | $8.35 M | -40.65% |
| 2015-06-30 | $14.07 M | 427.41% |
| 2014-06-30 | $2.66 M | 51.43% |
| 2013-06-30 | $1.76 M | -80.7% |
| 2012-06-30 | $9.13 M | 67.2% |
| 2011-06-30 | $5.46 M | 96.32% |
| 2010-06-30 | $2.78 M | -55.92% |
| 2009-06-30 | $6.3 M | -50.99% |
| 2008-06-30 | $12.87 M | 12.38% |
| 2007-06-30 | $11.45 M | 44.81% |
| 2006-06-30 | $7.91 M | -32.24% |
| 2005-06-30 | $11.67 M | 55.75% |
| 2004-06-30 | $7.49 M | 86.99% |
| 2003-06-30 | $4 M | -15.32% |
| 2002-06-30 | $4.73 M | 1007.76% |
| 2001-06-30 | $0.42 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $8.07 B | 317,454.55% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $0.47 B | 18,535.74% | 🇺🇸 USA |
 Danaher DHR | $7.03 B | 276,330.12% | 🇺🇸 USA |
 LabCorp LH | $99.3 M | 3,804.07% | 🇺🇸 USA |
 Compugen CGEN | $50.68 M | 1,892.73% | 🇮🇱 Israel |
 Neogen NEOG | $0.16 B | 6,522.65% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.14 B | 5,439.61% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $7.57 M | 197.82% | 🇺🇸 USA |